Track AI Answers

What does AI know about a brand?

TRACK BRANDS ON AI

Monitor your brand, company, or product's online reputation in AI responses

What does AI know about Kalvista Pharmaceuticals Inc?

What does OpenAI free version (gpt-3.5-turbo) know about Kalvista Pharmaceuticals Inc?

Last request 14.12.2023

(There is a high chance that below response is an AI hallucination)

Well Known No
Description Kalvista Pharmaceuticals Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of small molecule therapies for diseases with significant unmet medical need.
Most Notable Achievements Kalvista Pharmaceuticals Inc has a strong pipeline of potential treatments for a variety of diseases.
The Most Negative Fact Kalvista Pharmaceuticals Inc has yet to bring any of its treatments to market.
Competition None
Share with friends

Register your email below to unlock features!

Don't like the AI answers? Who can help me Change them?

What does OpenAI paid version (gpt-4) know about Kalvista Pharmaceuticals Inc?

Request date
Well Known No
Description Kalvista Pharmaceuticals Inc is a clinical stage pharmaceutical company focused on developing small molecule protease inhibitors for diseases with significant unmet need.
Most Notable Achievements Kalvista's lead product candidate, KVD900, has shown promising results in clinical trials for the treatment of hereditary angioedema.
The Most Negative Fact Kalvista has a limited pipeline and is heavily reliant on the success of KVD900.
Competition None
Share with friends

What does Google AI (PaLM) know about Kalvista Pharmaceuticals Inc?

Last request 14.12.2023
Well Known no
Description Kalvista Pharmaceuticals Inc. is a biopharmaceutical company that develops and commercializes novel, small molecule drugs for the treatment of cancer and other serious diseases.
Most Notable Achievements The company's lead product candidate, KVT-545, is a novel, oral, small molecule inhibitor of the bromodomain and extra-terminal domain (BET) family of proteins. BET proteins are key regulators of gene expression and are implicated in the development and progression of a wide range of cancers.
The Most Negative Fact The company is currently conducting a Phase 1 clinical trial of KVT-545 in patients with advanced solid tumors.
Competition None

What does Microsoft Bing AI know about Kalvista Pharmaceuticals Inc?

Well Known No
Description mil ,cnedeym apsnde atilclouiertnsplanlesaevlhraia s da eeiaroph ife sKeitot e s chmgcezda concllu dcv aniaimraecmoaeysvaibfdetsow c calfon semhie usm ,ltmti.aamorma Iiof dinnittctrsnPpuo u ehceic o
Most Notable Achievements lpli rhafay nrtnlop aatas neesivila mpetu asKeteIonotgtimssiies.eeacranr fd eao rvtaPt tssoifh acc
The Most Negative Fact iltnne teIat hyavitosulmreaa mtiichafct ktn g a bsmt.oncetrays aPsKo as tr re
Competition Nnoe

Register your email below to unlock features!

By signing up or logging in you agree to our Terms and Privacy Policy.